The Power of Drug Combinations: High Throughput BH3 Profiling in Mesothelioma
| |

The Power of Drug Combinations: High Throughput BH3 Profiling in Mesothelioma

A new technique called dynamic BH3 profiling tests drug combinations to treat mesothelioma. This testing can help doctors create effective treatment plans for individual patients. Mesothelioma is a type of cancer caused by exposure to asbestos. It is hard to diagnose and even harder to treat, especially when it is in advanced stages. Even in the early stages, the chances of survival after five years are only 18%. A Treatment Plan for Mesothelioma A treatment plan for malignant pleural mesothelioma depends on a few different factors. These include the type of mesothelioma and how far it has developed in the patient. It may also include the health of the patient and the patient’s wishes for treatment. Conventional treatment usually involves…

Precision Medicine Treatment: Gene-Targeting Mesothelioma
| |

Precision Medicine Treatment: Gene-Targeting Mesothelioma

A new precision medicine treatment for mesothelioma comes from scientists in Italy. This form of mesothelioma occurs after asbestos exposure in people with a genetic mutation. The mutation is represented by patients with an inherited cancer syndrome. These patients typically have an even worse prognosis than other mesothelioma patients. But the Italian team came up with a way to target the mutated gene. This form of treatment is called precision medicine. Precision medicine treatment looks at the genetics of a patient to select a treatment that will work best for them. Discovery of a DNA Gene Mutation Malignant pleural mesothelioma is a rare and aggressive cancer caused by exposure to asbestos. Malignant mesothelioma is one of the most aggressive kinds…